The clinical analysis of the factors influencing the therapeutic effect of INSURE technology in premature infants with respiratory distress syndrome
10.3969/j.issn.1000-3606.2015.07.006
- VernacularTitle:影响INSURE技术治疗早产儿呼吸窘迫综合征疗效因素的临床分析
- Author:
Yanrui WANG
;
Mingjie WANG
;
Xiaohe YU
;
Chuanding CAO
;
Huiyi HUO
;
Zhengchang LIAO
;
Shaojie YUE
- Publication Type:Journal Article
- Keywords:
INSURE technology;
neonatal respiratory distress syndrome;
premature infant
- From:
Journal of Clinical Pediatrics
2015;(7):621-626
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo assess the factors inlfuencing the therapeutic effects of INSURE technology in premature in-fants with respiratory distress syndrome (NRDS).MethodsThe clinical data from 309 infants with NRDS treated by INSURE technology were retrospectively analyzed from Jan. 2000 to Dec. 2012.ResultsIn 309 infants with NRDS, 302 infants were cured and the cure rate was 97.7%. Twenty-one infants (6.8%) needed the reintubation for mechanical ventilation within 72 h. The difference in reintubation rate was statistically signiifcant among infants with different gestational age (P<0.01). The infants with the gestation age≤28 weeks had a signiifcantly higher reintubation rate. According to whether the reintubation was performed, the infants were divided into success group and failure group. Compared to the success group, there were higher percentage of infants who had gestation age≤28 weeks, birth weight <1000 g and severe NRDS, needed high dose and repeated use of pulmo-nary surfactant and oxygen therapy, and had higher mortality in the failure group had (allP<0.05).ConclusionsThe INSURE technology can be effective in treatment of NRDS. Small gestational age, low birth weight, and severe NRDS are the risk factors for the failure of the INSURE technology.
